Denmark vs Switzerland live - international friendly live stream

go to the live match link >>>>>>>>>>> https://tinyurl.com/ysx6vb2c

The Truth About HPV Vaccination, Part 2: Studies Link the Vaccines to Neurological, Autoimmune Disorders
Researchers who looked closely into the Gardasil HPV vaccine concluded the risks from the vaccine seem to significantly outweigh the as-yet-unproven long-term benefits.

The Epoch Times

Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.

By Dr. Yuhong Dong

Editor’s Note: This second installment in a multi-part series about the human papillomavirus, or HPV, vaccine examines studies that link the vaccines to increased risk of serious neurological and autoimmune disorders. Read Part 1 here.

Summary of key facts

A Danish review of 79,102 female and 16,568 male subjects, found human papillomavirus (HPV) vaccines had significantly increased rates of serious nervous system disorders. Postural orthostatic tachycardia syndrome (POTS) and complex regional pain syndrome were judged “definitely associated” with the HPV vaccine.
A large Danish and Swedish study including nearly 300,000 girls found a significant association between the HPV vaccine and increased rates of Bechet’s syndrome (rate ratio 3.37), Raynaud’s disease (1.67) and type 1 diabetes (1.29).
A large study including 3 million Danish and Swedish women aged 18 to 44, identified seven adverse events with statistically significant increased risks following HPV vaccination: Hashimoto’s thyroiditis, celiac disease, lupus erythematosus, pemphigus vulgaris, Addison’s disease, Raynaud’s disease and encephalitis, myelitis, or encephalomyelitis.
A 2017 French study of over 2.2 million young girls found evidence of a 3.78-fold increased risk of Guillain-Barré syndrome (GBS). A 2011 U.S. study found nearly a two-and-a-half to 10 times greater risk of acquiring GBS within six weeks post-Gardasil vaccination.
While the underlying mechanisms causing these autoimmune reactions are not yet fully understood, some researchers speculate that the sizable overlap in protein sequences between the HPV and the human genome may cause the immune system to attack itself. Others are concerned that the adjuvants (such as aluminum) used to attract the attention of the immune system may be causing harm.
Neurological and autoimmune disorders

Danish review found increased nervous system disorder

In 2020, a group of Danish scientists conducted a systematic review of the overall benefits and harms of HPV vaccines.

Twenty-four eligible randomized controlled clinical studies were obtained, with a total of 95,670 participants, mostly women, and 49 months mean weighted follow-up.

Almost all controls were given an active comparator vaccine (typically a hepatitis vaccine with a comparable aluminum-based adjuvant).

Given that the adjuvant is highly immunogenic by design (it is meant to grab the attention of the immune system), this trial design makes it difficult to detect an excess risk with the HPV vaccines.

Without true controls (such as a saline placebo), the real risks of HPV vaccination cannot be accurately assessed.

In the vaccine group, 367 cancers were detected, compared to 490 in the comparator group.

Younger participants (15 to 29) seemed to benefit more from the vaccine concerning preventing moderate HPV-related intraepithelial neoplasia compared to older participants (ages 21 to 72). Younger participants also had fewer fatal harms.

Even though the studies were flawed in their design, at four years post-vaccination, those who had received the HPV vaccines had significantly increased rates of serious nervous system disorders: 49%, as well as general harms totaling 7%.

The serious harms that were judged “definitely associated” with HPV vaccines were postural orthostatic tachycardia syndrome and complex regional pain syndrome. POTS had a nearly twofold increase in the vaccinated group.

By July 2017, only two-thirds of the results from HPV vaccine trials had been published, and only about half the results had been posted, due to manuscript length limitations, reporting bias and confounding journal articles offering a limited view of trial outcomes.

This Danish systematic review compiled data from all the HPV trials to offer a summary of the evidence thus far.

Nevertheless, the investigators acknowledged that despite three years of work, the limitations of their analysis remained. These included reporting bias, incomplete reporting, data fragmentation and limited trial follow-up.

These investigators similarly note that the trials were powered to assess the benefits of HPV vaccination, not rare harms. The degree to which benefits outweigh risks is therefore unknown.

They concluded that future research should carefully evaluate the harms following Gardasil 9 compared to Gardasil because the former contains more than double the virus proteins and aluminum-containing adjuvant than the same dose of Gardasil.

RFK Jr. and Brian Hooker Vax-Unvax
RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax”

Order Now

Large studies reveal autoimmune events

In 2009, the HPV4 vaccine was integrated into the Danish childhood vaccination program. Since then, two large cohort studies on the HPV4 vaccine adverse events have been carried out using the hospital-based healthcare registries of Denmark and Sweden.

The first study in Denmark and Sweden included 296,826 girls aged 10 to 17 who received a total of 696,420 HPV4 vaccine doses.

The scientists evaluated rate ratios for autoimmune events and found no significant association for 20 out of 23 events.

They found a significant association between the HPV4 vaccine and Bechet’s syndrome (rate ratio 3.37), Raynaud’s disease (1.67) and type 1 diabetes (1.29).

But after further review, they concluded that there was insufficient evidence for a causal association, because of the weakness of the signal and the lack of an underlying mechanism to explain biological plausibility.

In a second large cohort study, the same team expanded their research to more than 3 million Danish and Swedish adult women aged 18 to 44.

The authors identified seven adverse events with statistically significant increased risks following HPV4 vaccination: Hashimoto’s thyroiditis, celiac disease, lupus erythematosus, pemphigus vulgaris, Addison’s disease, Raynaud’s disease and encephalitis, myelitis or encephalomyelitis.

After sensitivity analyses, the association between HPV4 vaccination and celiac disease was the most robust finding.

Celiac disease is a condition where a person’s immune system attacks the body’s own gut after eating gluten.

As the graph below shows, the scientists used two risk periods after HPV4 vaccination: the first 180 days and after.

1 time since first dose HPV4 vaccine coeliac cases
Time since the first dose of the HPV4 vaccine for vaccinated coeliac cases in a cohort of Danish and Swedish women. Credit: Journal of Internal Medicine
The authors noted that the observed 56% increased risk of celiac disease “was strong, and the increase was strikingly similar in both risk periods after vaccination.”

Celiac disease is underdiagnosed in Denmark.

So one possible explanation is that vaccination visits allow a chance for this and other conditions to be diagnosed and explored.

This explanation suggests that the association between the HPV vaccine and autoimmune disorders may be coincidental.

However, given the lack of any real control groups in these studies, as well as the growing body of scientific literature from countries around the world showing problems with the HPV vaccine, dismissing these safety signals as coincidence seems short-sighted.

Large French study and U.S. VAERS study identify risks of Guillain-Barré Syndrome

The concern about autoimmune disease adverse events has contributed to low HPV vaccination uptake in France.

A 2017 study of over 2.2 million young girls in France found troubling evidence of a link with Guillain-Barré syndrome. GBS is a condition that arises when our own antibodies attack the nerves.

The incidence of GBS was found to be 1.4 per 100,000 person-years among the vaccinated girls compared to 0.4 per 100,000 among the unvaccinated, resulting in an increased risk of GBS of more than 200%.

The association appeared to be “particularly marked in the first months following vaccination.”

This finding is corroborated by the pattern of adverse reactions reported worldwide. Data from a large number of case reports document similar serious adverse events associated with Gardasil administration, with nervous system disorders of autoimmune origin being the most frequently reported.

A 2011 U.S. study found that the estimated weekly reporting rate of post-Gardasil GBS within the first six weeks (6.6 per 10,000,000) was higher than in the general population, and higher than post-Menactra and post-influenza vaccinations.

In particular, there was nearly a two-and-a-half to 10 times greater risk of acquiring GBS within six weeks after vaccination, compared to the general population.

Additionally, the study found Gardasil vaccination was associated with approximately eight-and-a-half times more emergency department visits, 12.5 times more hospitalizations, 10 times more life-threatening events and 26.5 times more disability than the Menactra vaccination.

Plausible mechanisms of harm

Despite the conflicting data in the scientific literature to date, it is clear that the HPV vaccines can cause autoimmune disorders in susceptible people. But how?

Autoimmunity has been reported as a complication of natural infection as well as virus vaccination. This phenomenon has been observed with many viruses, including the Epstein-Barr virus, COVID-19 and HPV.

According to a 2019 study, the HPV vaccine contains epitopes — portions of the virus proteins — that overlap with the human proteins.

This means that if we develop antibodies to those viruses, we may also generate autoantibodies to our own cells, which is the root cause of autoimmune dysfunction.

The study showed that most of the immunoreactive HPV L1 epi­topes are overlapping peptides present in human proteins.

The authors explained that this “unexpected enormous size of the peptide overlap between the HPV epitopes and human proteins” is relevant, and may be why a wide variety of autoimmune diseases have been reported post-HPV vaccination, including ovarian failure, systemic lupus erythematosus, breast cancer and sudden death, among others.

Why some people develop these conditions and others do not is unclear.

The authors suggest that vaccines should target the few peptides that do not overlap with human proteins, but which do overlap with the other HPVs.

Despite this overlap and the potential for causing autoimmune disease, medical doctors usually ignore or dismiss the connection. We are told that these diseases are rare.

The human body has something called immune tolerance. This protects a person’s immune system against attacking itself. Therefore, HPV infection is also “immune tolerated,” which means it lays dormant for some time until it becomes cancerous.

HPV vaccination was actually designed with this immune tolerance in mind.

Given the human body’s built-in defenses against autoimmune conditions, vaccinology requires an immunogenic catalyst to get the body’s attention. This is the job of an adjuvant.

An adjuvant is an ingredient used in a vaccine that the body recognizes as foreign. It is added to vaccines so that the body will mount a stronger immune response.

The idea is that in attacking the adjuvant, the body will also recognize other vaccine ingredients (in this case, purified HPV proteins).

In addition, the antigen dose is much higher than in natural infections and the capsids in the vaccine are directly exposed to systemic immune responses as opposed to the virus staying relatively hidden within the natural barrier of the skin following infection.

The vaccine was well-designed to trigger an immune response, but this advantage may come at a cost: Generating antibodies to HPV proteins through vaccination could, theoretically, set the stage for an autoimmune attack.

Link between HPV-vaccine-associated nervous system dysfunction and autoimmunity

A December 2022 Danish and German study was designed to elucidate a possible mechanism of harm.

The lead author, Dr. Jesper Mehlsen, a specialist in treating autoimmune conditions, noted that the HPV major capsid L1s antigen resembles human autonomic nerve receptors, including G-protein coupled receptors (GPCR).

According to the researchers, in the past several years, case series of suspected vaccination side effects have pointed to three disease entities: POTS, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and complex regional pain syndrome. These syndromes may be associated with neuroendocrine GPCR antibodies.

From 2011 to 2018, researchers saw 845 patients (839 females, six males) with suspected side effects following the HPV4 vaccine. The control group included vaccinated people without side effects.

Moderate to severe fatigue was recorded in 83.3% of the patients but in none of the controls.

A high prevalence of symptoms, such as dizziness (91%), heart palpitations (71%), nausea (80%) and hyperactive bladder suggested that the patients were experiencing some kind of autonomic dysfunction.

Autonomic dysfunction occurs when the part of the nervous system that controls well-being and balance does not function properly.

2 most frequent symptoms hpv vaccine
Most frequent symptoms reported by 612 patients in Denmark. Credit: Journal of Autoimmunity
Twenty-four percent higher antinuclear antibodies (ANA, a common type of autoantibodies) were found in patients, suggesting possible autoimmunity.

3 antinuclear antibodies HPV vaccines
A larger proportion of the symptomatic patients were found with a common type of autoantibodies compared to healthy controls. Credit: Journal of Autoimmunity
Antibodies against the adrenergic ß-2-receptor and muscarinic M-2 receptors were also found significantly higher in patients.

Many of the symptoms, including immune activation and autonomic dysregulation, could be mediated or aggravated by dysregulated autoantibodies against adrenergic receptors and impaired peripheral adrenergic function.

The authors suggested that girls and women with probable side effects of HPV vaccination have symptoms and biological markers compatible with an autoimmune disease closely resembling that seen in ME/CFS.

Interestingly, people who already had HPV infections at some point appeared to be at greater risk for adverse events following vaccination.

The authors noted that “prior disease may precondition some individuals for vaccine-related adverse events.”

They also noted that some of the adverse events resembled long-COVID symptoms.

Universal HPV vaccination called into question

Academic researcher at the University of British Columbia, Lucija Tomljenovic, and neuroscientist Christopher Shaw, who have closely looked into Gardasil, have argued that the risks from the vaccine seem to significantly outweigh the as-yet-unproven long-term benefits.

In a 2012 comment published in the American Journal of Public Health, they took issue with “incomplete and inaccurate” data and poorly designed trials.

Vaccination is unjustified if the vaccine carries any substantial risk, as healthy teenagers face little to no risk of dying from cervical cancer.

Risk-benefit analyses must be conducted to ascertain the overall balance of benefits and harms on both individual and societal levels.

Reprinted with permission from The Epoch Times. Dr. Yuhong Dong, a medical doctor who also holds a doctorate in infectious diseases in China, is the chief scientific officer and co-founder of a Swiss biotech company and former senior medical scientific expert for antiviral drug development at Novartis Pharma in Switzerland.

If you or your child suffered harm after receiving the Gardasil HPV vaccine, you may have a legal claim. Please visit Wisner Baum for a free case evaluation. Click here to watch a Gardasil litigation update interview with Wisner Baum Senior Partner Bijan Esfandiari.

The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children's Health Defense.

https://childrenshealthdefense.org/defender/truth-hpv-vaccine-part-2-et/

https://donshafi911.blogspot.com/2024/01/the-truth-about-hpv-vaccination-part-2.html

The Truth About HPV Vaccination, Part 1: How Safe Is It, Really?
This first installment in a multi-part series about the human papillomavirus, or HPV, vaccine explores peer-reviewed scientific literature that reveals serious safety concerns about a vaccine widely regarded as safe.

The Epoch Times

Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.

By Yuhong Dong

The decline of public trust in COVID-19 vaccines significantly impacts vaccination rates against routine childhood diseases. This multiple-part series explores the international research done over the past two decades on the human papillomavirus (HPV) vaccine — believed to be one of the most effective vaccines developed to date.

Summary of Key Facts

This multiple-part series offers a thorough analysis of concerns raised about HPV vaccination following the global HPV campaign, which commenced in 2006.
In the U.S., the HPV vaccine was reported to have a disproportionately higher percentage of adverse events of fainting and blood clots in the veins. The U.S. Food and Drug Administration (FDA) acknowledges that fainting can happen following the HPV vaccine, and recommends sitting or lying down to get the shot, then waiting for 15 minutes afterward.
International scientists found that the Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS) logged a substantial increase in reports of premature ovarian failure from 1.4 per year before 2006 to 22.2 per year after the HPV vaccine approval, yielding a Proportional Reporting Ratio of 46.1.
The HPV vaccine is widely regarded as one of the most effective vaccines developed to date. Nevertheless, safety issues have been raised following its approval, and in response, additional research has been published and litigation has been brought on behalf of those with a vaccine injury.

In this HPV vaccine series, Parts I and II explain how the vaccine works and the evidence suggesting there may be legitimate safety concerns. The remaining parts present questions about real-world vaccine effectiveness and identify specific ingredients which may pose harm.

The information presented here is drawn from peer-reviewed scientific literature from the U.S., Australia, Denmark, Sweden, France and Japan, as well as statistics published by public health agencies in each of these countries.

More than 100 hours of research and internal peer review among scientists with experience in infectious diseases, virology, clinical trials and vaccine epidemiology have been invested in presenting this summary of the evidence.

Large registry-based studies have identified plausible associations between HPV vaccination and autoimmune conditions, including premature ovarian insufficiency or premature ovarian failure, Guillain-Barré syndrome (GBS), postural orthostatic tachycardia syndrome and chronic regional pain syndrome.

While it is easy to be enthusiastic about recent advances in human vaccine technology, we should keep in mind that achieving real and lasting good health is much more than just the absence of a certain virus.

RFK Jr. and Brian Hooker Vax-Unvax
RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax”

Order Now

What is HPV?

According to the CDC, HPV is the most common sexually transmitted infection in the U.S.

HPV is a small DNA virus infecting human cutaneous epithelial cells in the mucosa and skin. More than 150 strains of the HPV virus have been identified.

HPV infection is so common that the majority of sexually active people will get it at some point in their lives, even if they have only one or very few sexual partners. It can spread through sexual intercourse and oral sex. It can also pass between people through skin-to-skin contact, even by people who have no symptoms.

HPV infection causes genital warts, some of which can turn into cancer. For the most part, however, HPV infection is benign. More than 90% of HPV infections cause no clinical symptoms and are self-limited, meaning the virus is cleared by the body via natural immunological defenses.

HPV-associated cancers

High-risk HPV types (types 16, 18 and others) can cause cervical cell abnormalities that are precursors to cancers.

Type 16 is associated with approximately 50% of cervical cancers worldwide, and types 16 and 18 together are linked to 66% of cervical cancers.

An additional five high-risk types, 31, 33, 45, 52 and 58, are linked with another 15% of cervical cancers and 11% of all HPV-associated cancers.

Infection with a high-risk HPV type is associated with a higher chance of the development of cervical cancer but, by itself, HPV infection is not the sole risk factor to cause cancer. There are many other reasons, as discussed in this paper.

Given the prevalence of infection, it is unsurprising that globally, cervical cancer is the fourth most common cancer in women. In 2018, an estimated 570,000 women were diagnosed with cervical cancer worldwide and more than 300,000 died of the disease.

In the U.S., nearly 50,000 new HPV-associated cancers occur annually, with women infected at a slightly higher rate than men.

But in 9 out of 10 cases, HPV goes away within two years without causing health problems.

Only persistent HPV infections may lead to cancer. These infections evade the immune system’s innate cell-mediated defenses.

The incidence of cervical cancer can be controlled as a result of the implementation of routine testing and screening, including Pap and DNA tests.

HPV vaccines

Three HPV vaccines — bivalent HPV vaccine (Cervarix, 2vHPV), quadrivalent HPV vaccine (Gardasil, 4vHPV or HPV4) and 9-valent HPV vaccine (Gardasil 9, 9vHPV) — have been licensed by the FDA.

The HPV vaccine uses recombinant technology to assemble the shell of the virus — L1 capsid protein. These viral-like particles do not contain the virus genome and are not infectious.

Cervarix, developed by GlaxoSmithKline, is a bivalent vaccine against HPV types 16 and 18, that was pulled from the U.S. market in 2016 due to “very low market demand.”

Merck’s original Gardasil vaccine was designed to prevent infections from four strains (types 6, 11, 16 and 18).

On June 8, 2006, after the FDA’s fast-tracked review, Gardasil was approved for use in females ages 9 to 26 for the prevention of cervical, vulvar and vaginal cancers.

According to the label accompanying the vaccine, the ingredients in Merck’s first Gardasil vaccine were proteins of HPV, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate and water for injection.

On Oct. 16, 2009, the FDA approved Gardasil (HPV4) for use in boys ages 9 through 26 for the prevention of genital warts caused by HPV types 6 and 11, but not for cancer.

In 2010, it approved Gardasil for the prevention of anal cancer in males and females ages 9 to 26.

Four years later, the FDA approved an updated vaccine, Merck’s Gardasil 9, for use in girls ages 9 to 26 and boys ages 9 to 15 for the prevention of cervical, vaginal and anal cancers.

Gardasil 9 contains the same ingredients as Gardasil, but offers protection against nine HPV strains, adding five additional types (HPV types 31, 33, 45, 52 and 58).

The current HPV vaccination schedule recommended by the CDC is two doses for both boys and girls aged 11 or 12. However, it is approved for children as young as 9. The second dose is given 6 to 12 months after the first.

For those aged 15 and above, a three-dose schedule is implemented at one- to two-month and six-month intervals, although antibody-level studies suggest that two doses are sufficient.

The vaccine prompts the body to produce neutralizing antibodies against HPV. Antibody responses appear to peak seven months after the first dose (or one month after the third dose). The vaccine-induced antibody levels appear to be 10 to 100 times higher than those after natural infection.

The high vaccine effectiveness (90 to 98%) against the fast-growing, abnormal cells which may cause precancerous lesions in people ages 16 to 26 suggested that the best timing for vaccination was to give it to patients before they became sexually active.

HPV VAERS reports from 2 large countries

U.S. HPV vaccine adverse events

On Aug. 19, 2009, the Journal of the American Medical Association published an article authored by scientists from the FDA and CDC that reviewed the safety data for Gardasil for adverse events reported to VAERS between June 2006 through December 2008.

During that time, there were 12,424 reports of adverse events. Of these, 772 (6.2%) were serious.

VAERS is a passive surveillance system, which is subject to multiple limitations, including underreporting, unconfirmed diagnosis, lack of denominator data and no unbiased comparison groups.

Nevertheless, it is a useful and important tool for detecting postmarket safety issues with vaccines.

A disproportionately high percentage of Gardasil VAERS reports were of syncope (fainting) and venous thromboembolic events (blood clots in the veins) compared with other vaccines. There were 8.2 syncope events per 100,000 HPV doses and 0.2 venous thromboembolic events per 100,000 HPV doses reported, respectively.

The Gardasil package insert includes a warning about fainting, fever, dizziness, nausea and headaches (page 1) and notes at least the following adverse reactions reported during postmarketing surveillance (section 6.2): Guillain-Barré syndrome, transverse myelitis, motor neuron disease, venous thromboembolic events, pancreatitis and autoimmune disorders.

Australia HPV vaccines adverse events

In 2007, Australia reported an annual adverse drug reaction rate of 7.3/100,000, the highest since 2003, representing an 85% increase from 2006.

Per the analysis of the Adverse Drug Reactions System database by the Australian Department of Health and Aging, this increase was “almost entirely due to” reports following the national rollout of the three-dose HPV vaccination program for young females in April 2007; 705 of the 1,538 adverse drug reactions reported that year were from the Gardasil vaccine.

1 vaccine adverse events australia chart
In Australia, the ADR increase in 2007 was almost entirely due to the three-dose HPV vaccination program for females aged 12 to 26 years in April 2007. Credit: Australian Government Department of Health and Aged Care.
Moreover, though people may take different vaccines other than HPV, the HPV vaccine was the only suspected vaccine to cause adverse reactions in 96% of records. Twenty-nine percent had causality ratings of “certain” or “probable” and 6% were defined as “serious.”

2 vaccine types vaccine suspected chart
In these HPV-induced ADRs, 674 were suspected to be related to HPV vaccines, 203 had causality ratings of “certain” or “probable,” and 43 were defined as “serious.” Credit: Australian Government Department of Health and Aged Care.
Japan withdraws recommendation, vaccine acceptance plunged

In 2013, the Japanese raised concerns about a variety of widely reported post-vaccination serious adverse events. This led the government to suspend recommending the HPV vaccine for six years. Vaccine acceptance of HPV in Japan plunged significantly after 2013, from 42.9% to 14.3%, or from 65.4% to 3.9%.

Researchers around the world also started to investigate HPV safety. A World Health Organization (WHO) position paper released on July 14, 2017, concluded that the HPV vaccines were “extremely safe.”

The same report estimated approximately 1.7 cases of anaphylaxis per million HPV doses, that no association with GBS was found, and that syncope (fainting) was “established as a common anxiety or stress-related reaction to the injection.”

In the spring of 2022, Japan announced it was relaunching its HPV vaccination drive. Mainstream news outlets reported that for thousands of women, the cost of caution may have led to preventable HPV-induced cancers and an estimated 5,000 to 5,700 deaths.

However, a true risk-benefit analysis would also consider the number of serious adverse events prevented by putting the program on hold. The question remains: Was Japan’s caution warranted, or should their national vaccination program have continued?

Ovarian insufficiency

Concerns that the vaccine may be negatively affecting fertility have been detailed in the scientific literature.

In 2014, a peer-reviewed case series describing premature ovarian failure among Australian women following HPV vaccination was published in the Journal of Investigative Medicine.

This prompted other researchers to systematically examine the VAERS data to see if there was a connection between premature ovarian failure and Gardasil. Their study found a “potential safety signal” and concluded that “further investigations are warranted.”

VAERS analysis on ovarian failure

Two recent publications based on VAERS reports (first study, second study) found that events with a probable autoimmune background were significantly more frequent after HPV vaccination compared to other vaccinations.

The team of international scientists that did the second study evaluated reports between 1990 and 2018. They found that among the 228,341 premature ovarian failure reports, 0.1% was considered to be associated with HPV vaccination with a median age of 15 years and the time to onset was 20.5 days following vaccination.

The primary symptoms were amenorrhea (80.4%) and premature menopause (15.3%).

Most strikingly, the mean number of premature ovarian failure cases increased significantly from 1.4 per year prior to 2006 to 22.2 per year after the HPV vaccine was approved, with a proportional reporting ratio of 46.

The investigators noted that the WHO and CDC declared the HPV vaccine safe regardless of lacking adequate research into safety concerns.

For example, the authors note that in a CDC-sponsored VAERS study, 17 cases of premature ovarian failure were identified but 15 were excluded due to insufficient information to confirm the diagnosis. A separate observational study using the Vaccine Safety Datalink found no increased risk.

But this study was too underpowered to detect a signal. In addition, a cross-sectional survey study using National Health and Nutrition Examination Survey data relied on an inaccurate measurement of premature ovarian failure and self-reported HPV vaccination.

In summary, the researchers detected a strong safety signal even after accounting for a potential upswing in reports due to media coverage after the product launch (they refer to this as “notoriety bias”).

Because VAERS is a passive reporting system, the data may be incomplete and are often unconfirmed by physicians. Therefore, this study cannot provide a definitive link between HPV vaccination and premature ovarian insufficiency or premature ovarian failure but does generate a hypothetical link.

The authors of the second study conclude by insisting that “this signal warrants well-designed and appropriate epidemiological research.” They note that “if the signal is confirmed, the risk is small compared to the lifetime risk of cervical cancer.”

However, the benefit-risk profile on an individual level is not uniform.

Given the health impacts of premature ovarian insufficiency and premature ovarian failure — some of which may be irreversible — and the declining mortality rate for cervical cancer even in the prevaccine era, the risk-benefit profile for HPV vaccination remains unclear.

3 case reports on ovarian insufficiency

In the 2014 investigation mentioned above, a general practitioner in Australia noticed that three girls developed premature ovarian insufficiency following HPV4 vaccination.

As a result of vaccination, each of the girls (ages 16, 16 and 18) had been prescribed oral contraception to treat menstrual cycle irregularities. Typically, women present with amenorrhea (no periods) or oligomenorrhea (infrequent periods) as the initial symptom of premature ovarian insufficiency.

One girl had irregular periods following three doses of HPV vaccination. She then became amenorrheic and was diagnosed with premature ovarian insufficiency.

Another girl’s periods were “like clockwork” until after the third HPV dose, which she received at age 15. Her first cycle after being vaccinated for the third time started two weeks late, and her next cycle was two months late. The final cycle began nine months later. The patient had no family history of early menopause.

She was diagnosed with premature ovarian failure at 16. Lab work found hormone levels consistent with those of postmenopausal women, but her bone mineral density was normal.

The authors of this case series noted that in preclinical studies of HPV4, the five-week-old rats only conceived one litter and the only available toxicology studies appear to be on the male rodent reproductive system.

However, only two of three doses were administered prior to mating, and the overall fecundity was 95%, slightly lower than the control rats (98%) that received no vaccination prior to mating.

The dose tolerance recommendations were based on an average weight of 50 kilograms for an adolescent girl but failed to take into account that HPV4 is administered to girls ages 9 to 13 years, who range in weight from 28 to 46 kilograms.

Danish retrospective cohort study finds no link

A 2021 study also evaluated premature ovarian insufficiency in a nationwide cohort of nearly 1 million Danish females ages 11 to 34 years.

The researchers used Cox proportional hazard regression to detect an increased risk of premature ovarian insufficiency diagnosis by HPV4 vaccination status during the years 2007-2016. The hazard ratio for premature ovarian insufficiency (vaccinated versus unvaccinated) was 0.96.

One limitation was that data on age at menarche (first menstruation) and oral contraceptive use were not available. Girls who had not yet reached menarche would not be at risk for premature ovarian insufficiency, of course.

The authors excluded girls under age 15 in a sensitivity analysis and still found no signal, concluding that no association was found between HPV4 vaccination and premature ovarian insufficiency.

Reprinted with permission from The Epoch Times. Dr. Yuhong Dong, a medical doctor who also holds a doctorate in infectious diseases from China, is the chief scientific officer and co-founder of a Swiss biotech company and a former senior medical scientific expert for antiviral drug development at Novartis Pharma in Switzerland.

If you or your child suffered harm after receiving the Gardasil HPV vaccine, you may have a legal claim. Please visit Wisner Baum for a free case evaluation. Click here to watch a Gardasil litigation update interview with Wisner Baum Senior Partner Bijan Esfandiari.

The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children's Health Defense.

https://childrenshealthdefense.org/defender/hpv-vaccine-safety-concerns-part-1-et/


https://donshafi911.blogspot.com/2024/01/the-truth-about-hpv-vaccination-part-1.html

‘Operation Al-Aqsa Flood’ Day 114: UN chief urges Western countries to restore funding to UNRWA
Thousands of Israelis protested in Tel Aviv and Jerusalem calling on Netanyahu to resign, while others attempt to block aid trucks from entering Gaza. Meanwhile, the UN sad it has suspended the employees who Israel alleges took part in October 7.

Mustafa Abu SneinehJanuary 28, 2024
Displaced Palestinians on the move after the Israeli army ordered Khan Younis camp residents to leave for Rafah near the Egyptian border, south of the Gaza Strip, January 26, 2024. (Photo: © Haitham Imad/EFE via ZUMA Press APA Images)
Displaced Palestinians on the move after the Israeli army ordered Khan Younis camp residents to leave for Rafah near the Egyptian border, south of the Gaza Strip, January 26, 2024. (Photo: © Haitham Imad/EFE via ZUMA Press APA Images)
Casualties

26,422+ killed* and at least 65,087 wounded in the Gaza Strip.
387+ Palestinians killed in the occupied West Bank and East Jerusalem
Israel revises its estimated October 7 death toll down from 1,400 to 1,147.
557 Israeli soldiers killed since October 7, and at least 3,221 injured.**
*This figure was confirmed by Gaza’s Ministry of Health. Some rights groups put the death toll number closer to 32,000 when accounting for those presumed dead.

** This figure is released by the Israeli military.

Key Developments

UN chief says nine of 12 UNRWA employees accused by Israel of being involved in October 7 attack were suspended.
UN chief appeals to U.S. and “governments that have suspended their contributions to, at least, guarantee the continuity of UNRWA’s operations.”
Palestinian who fled to Rafah says, “when I arrived here, I did not find a bite of food or a tent. I slept in the street under the rain…This is the hardest war. I witnessed all wars [in Gaza]. I’m 70 years old, this is the toughest of all.”
Palestinians bury 150 martyrs in yard of Nasser Hospital in Khan Yunis as Israeli tanks lay siege to compound.
Gaza Ministry of Health says 30 bodies remain unidentified in mortuary as anyone who leaves or enters Nasser Hospital is at risk of being shot by Israeli forces.
Amal Hospital in Khan Yunis warns it has run out of oxygen due to ongoing siege imposed by Israeli forces for past week.
Hundreds of Israeli protestors attempt to block entry of humanitarian aid into Gaza from Karem Abu Salem crossing.
Israeli police disperse and arrest protestors in West Jerusalem calling for Prime Minister Benjamin Netanyahu to resign.
Israeli forces hand body of Salim Nasser Abu Hajar from Tulkarm, after killing him in mid-December.
Islamic Jihad’s Al-Quds Brigades says it detonated an explosive device in an Israeli infantry force in Qabatiya in northern West Bank.
UN chief urges U.S. to restore funding to UNRWA

The UN chief, Antonio Guterres, called on the U.S. and its European allies to restore the funding to the UN agency for Palestinian refugees (UNRWA) as millions in the Gaza Strip are in urgent need of humanitarian support.

Advertisement

Mondoweiss publishes news and analysis about Palestine for people taking action. Donate today.
Guterres said that UNRWA would investigate the Israeli claim that 12 UN employees took part in Operation Al-Aqsa Flood on October 7.

Guterres added that nine of the 12 employees accused by Israel of being involved in the attack have been suspended. UNRWA employs 30,000 workers, 13,000 in Gaza, and the rest in Lebanon, Syria, Jordan, and the occupied West Bank.

Since December 1949, it has operated schools, health clinics, food banks, and youth centers, among other humanitarian services essential to Palestinian refugees who were forcibly expelled from homes and towns by Zionist militias in 1948.

The U.S., Canada, Australia, and other European states are now pausing their funding to UNRWA.

“While I understand their concerns, I was myself horrified by these accusations, I strongly appeal to the governments that have suspended their contributions to, at least, guarantee the continuity of UNRWA’s operations,” Guterres said in a statement Saturday evening.

For second time since 2018, U.S. halts donations to UNRWA

The U.S. is the biggest donor to UNRWA, paying $153 million to the agency in 2023, and $343 million during 2022, according to UNRWA official figures.

Guterres said “the tens of thousands of men and women who work for UNRWA, many in some of the most dangerous situations for humanitarian workers, should not be penalized. The dire needs of the desperate populations they serve must be met.”

Israeli bombardment killed at least 152 UN workers in the Gaza Strip since October 7.

Prior to that, the U.S. has ended funding to UNRWA for almost three years. In 2018, former U.S. President Donald Trump announced that Washington is not going to donate the full sum of money pledged to UNRWA, accusing the agency’s institutions of being “irredeemably flawed.”

Trump’s decision was hailed by Israel and fit perfectly with the Likud ruling party’s agenda to end the cause of Palestinian refugees, who number in the millions and are still calling for their right to return to lands and homes occupied by Zionist militias in what became the present-day state of Israel.

A Likud lawmaker, Anat Berko, summoned the Israeli position at that time, telling CNN that “an end to UNRWA will bring an end to the ‘refugee forever’ status. We cannot solve any conflict with this definition of refugees. Humanitarian aid — yes. But UNRWA — no.”

UNRWA has been a lifeline for tens of thousands of Palestinians in the Gaza Strip, who sought shelter from Israeli bombardment in its facilities and schools.

UNRWA has also been a reliable and independent source to comprehend the plight of thousands of Palestinians who have endured constant Israeli bombardment, internet and telecommunications blackouts, and forced displacement since October.

The International Court of Justice (ICJ), where Israel sat in the dock to face accusations of committing genocide, had cited and quoted UNRWA’s officials and reports during the hearings, and also during its ruling on Friday, which ordered Israel to “prevent genocidal actions” in Gaza.

‘I did not find a bite of food or a tent. I slept under the rain.’

Israel’s bombardment in the Gaza Strip has resulted in the displacement of almost two million Palestinians. Most of them were forced into Rafah, Gaza’s southernmost city bordering Egypt’s Sinai.

The Palestinian population in Gaza is made up of 80 percent refugees from 1948, and have now been displaced yet again 75 years later, reliving the trauma that their grandparents endured during the Nakba.

In Rafah, thousands of Palestinian families spent their Saturday in tents under heavy rains, cooking their meals on stoves, and digging channels to direct the flooded water away from their mattresses.

A Palestinian told Al-Jazeera Arabic while on a ladder fixing his tent with heavy-duty nylon tarps that his family had been displaced three times, from Gaza to Al-Nuseirat, to Khan Yunis, and now to Rafah.

Not every Palestinian could leave northern Gaza or Khan Younis, and many have now opted to build shelters on top the rubble of their levelled houses, using whatever material they could find amidst the rubble to shields themselves from the elements.

Oum Imad, a Palestinian resident of Abbsan town, told Wafa that she walked for three days to arrive in Rafah.

“When I arrived here, I did not find a bite of food or a tent. I slept in the street under the rain…I am accompanied by orphaned children, without a mother or father. This is the hardest war. I witnessed all wars [in Gaza]. I’m 70 years old, this is the toughest of all,” she said.

Palestinians bury relatives in Nasser Hospital as Israeli forces lay siege to Khan Younis

On Saturday evening, Palestinians buried 150 martyrs in the yard of the Nasser Hospital in Khan Younis in southern Gaza, as Israeli tanks laid siege to the facility.

Gaza’s Ministry of Health said that 30 bodies remain unidentified in the mortuary as anyone leaving or entering the Nasser Hospital is at risk of being shot by Israeli forces.

On Sunday, the ministry said that Israel committed 19 massacres in the Gaza Strip, killing 165 Palestinian martyrs and injuring 290 in the past 24 hours.

Israel killed 26,422 Palestinians and 65,087 people in the Gaza Strip since October.

“A number of victims are still under the rubble and on the roads. The occupation prevents ambulances and civil defense crews from reaching them,” the ministry added on its Telegram channel.

The Nasser Hospital, the largest medical facility in southern Gaza, is facing “a severe and dangerous shortage of blood units, and many anesthesia drugs have run out,” the ministry said.

The Palestinian Red Crescent Society (PRCS) also warned on Sunday that the Amal Hospital in Khan Younis had run out of oxygen due to the ongoing siege imposed by Israeli forces for the past week.

Since Monday, Israeli forces have bombed several areas in the vicinity of the Al-Amal and Nasser Hospitals in Khan Younis. It also stormed the Al-Khair Hospital and arrested a number of medical staff. There are only 14 hospitals partially operating in the Gaza Strip, nine of which are in the south, and the rest are in northern Gaza.

Israeli artillery and military planes bombed several areas in the Gaza Strip in the past 24 hours. In north Gaza’s Al-Zaytoun neighborhood, an Israeli air strike killed eight Palestinians and injured dozens, according to Wafa news agency.

Israeli forces also bombed Al-Maghazi refugee camp, Khan Younis’s Batn Al-Sameen, Al-Malalha, and Jourat Al-Aqqad areas.

Protests in Tel Aviv and Jerusalem; thousands march in Europe in support of Palestinians

On Sunday morning, hundreds of Israeli protestors attempted to block the entry of humanitarian aid into the Gaza Strip from Karam Abu Salem crossing.

The protestors have called for the release of all Israeli captives in Gaza before allowing any aid trucks to enter. The protests are organized by the Order 9 movement, made up of the families of captives, settlers from the occupied West Bank, and Kibbutzniks. Attempts to block aid to Gaza by Order 9 have been growing since last week.

On Sunday, Israeli police dispersed and arrested some protestors in West Jerusalem, calling for Israel’s Prime Minister Benjamin Netanyahu to resign. Tens of thousands of Israelis also protested in Tel Aviv, calling for an election and the release of captives in Gaza.

In the wake of South Africa’s genocide case against Israel at the ICJ, the mayor of Rishon Lezion, south of Tel Aviv, ordered the removal of the South African flag.

Meanwhile, in solidarity with Palestinians in the Gaza Strip, hundreds of thousands of citizens marched on Saturday in demonstrations in several cities and capitals of Europe, including Berlin, Vienna, Denmark’s Odense, and Rotterdam, to name a few.

Israeli forces raid towns in West Bank, Palestinians detonate explosive device in Qabatiya

In the past 24 hours, Israeli forces arrested 22 Palestinians from the towns of Ramallah, Jenin, Burqin, Bethlehem, and Silwan.

Israeli forces handed the body of Salim Nasser Abu Hajar from the Shweika area, north of Tulkarem, after holding him for several weeks. Israeli forces shot Abu Hajar, 25, and arrested his brother near the village of Deir Al-Ghusoun, north of Tulkarem, on December 16, 2023.

On Sunday morning, Israeli forces stormed the village of Tayasir, east of Tubas, while on Saturday evening, Israeli forces stormed the villages of Beit Rima and Deir Ghassaneh, northwest of Ramallah, which were resisted by Palestinians.

Israeli forces were raiding the house of Othman Al-Assi to arrest his son Nader, who was not at home, and interrogated the family, Wafa reported.

Israeli forces also stormed the towns of Jenin and Qabatiya and clashed with Palestinian resistance fighters. In Qabatiya, the Islamic Jihad’s Al-Quds Brigades said that it detonated an explosive device in an Israeli infantry force in the town.

BEFORE YOU GO – At Mondoweiss, we understand the power of telling Palestinian stories. For 17 years, we have pushed back when the mainstream media published lies or echoed politicians’ hateful rhetoric. Now, Palestinian voices are more important than ever.

Our traffic has increased ten times since October 7, and we need your help to cover our increased expenses.

Support our journalists with a donation today.

https://mondoweiss.net/2024/01/operation-al-aqsa-flood-day-114-un-chief-urges-western-countries-to-restore-funding-to-unrwa/

German Scientists Uncover Evidence that EU Pfizer-BioNTech Batches Included Placebos
Robert Kogon
German scientists have uncovered startling evidence that a substantial portion of the batches of the Pfizer-BioNTech Covid-19 vaccine deployed in the European Union may in fact have consisted of placebos – and hence were not even subjected to quality-control testing by the German agency which was in principle responsible for approving their release.

The scientists, Dr. Gerald Dyker, Professor of Organic Chemistry at the Ruhr University Bochum, and Dr. Jörg Matysik, Professor of Analytical Chemistry at the University of Leipzig, are part of a group of five German-speaking scientists who have been publicly raising questions about the quality and safety of the BioNTech vaccine (as it is known in Germany) for the last year and a half.

They recently appeared on the Punkt.Preradovic online program of the German journalist Milena Preradovic to discuss batch variability. Their starting point was the recent Danish study showing enormous variation in the adverse events associated with different batches of the Pfizer-BioNTech vaccine or BNT162b2 per its scientific codename. The below figure from the Danish study illustrates this variation.


It shows that the batches used in Denmark, which are represented by the points in the graph, essentially break down into three groups.

The “green batches” clustered around the green line have a moderate or moderately-high level of adverse events associated with them. In the discussion with Preradovic, Gerald Dyker takes the example of the green point furthest to the right.

As he explains, it represents the batch that was used the most in Denmark, with somewhat over 800,000 doses having been administered. These 800,000 doses are associated with around 2,000 suspected adverse events, which gives a reporting rate of one suspected adverse event per approximately 400 doses. As Dyker puts it, “That’s not a small amount if we compare to what we know otherwise from influenza vaccines.” According to Dyker’s calculation, the green batches account for more than 60 percent of the Danish sample.

There are then the “blue batches” clustered around the blue line, which are obviously associated with an extraordinarily high level of adverse events. As Dyker notes, no more than 80,000 doses of any of the blue batches were administered in Denmark – suggesting that these especially bad batches may perhaps have been quietly pulled from the market by public health authorities.

Nonetheless, these batches had as many as 8,000 suspected adverse events associated with them. Eight thousand out of 80,000 doses would give a reporting rate of one suspected adverse event for every ten doses – and Dyker notes that some of the blue batches are indeed associated with a reporting rate of as high as one suspected adverse event for every six doses!

On Dyker’s calculation, the blue batches represent less than 5 percent of the total number of doses included in the Danish study. Nonetheless, they are associated with nearly 50 percent of the 579 deaths recorded in the sample.

Finally, we have the “yellow batches” clustered around the yellow line, which, as can be seen above, barely gets off the x-axis. On Dyker’s calculation, the yellow batches represent around 30 percent of the total. Dyker notes that they include batches comprising some 200,000 administered doses which are associated with literally zero suspected adverse events.

As Dyker puts it, “malicious” observers might note that “this is how placebos would look.”

And malicious observers might be right. For Dyker and Matysik compared the batch numbers contained in the Danish study with publicly available information on the batches approved for release, and they made the startling discovery that almost none of the harmless batches, unlike the very-bad and not-so-bad batches, appear to have been subject to any quality-control testing at all.

Unbeknownst to most observers, it is precisely the German regulatory agency, the Paul Ehrlich Institute (PEI), which is, in principle, responsible for quality control of all the Pfizer-BioNTech vaccine supply in the EU. (The institute is named after the German immunologist and Nobel Prize winner Paul Ehrlich, not, of course, the Stanford biology professor of the same name.)

This reflects the fact that the actual legal manufacturer of the vaccine, as well as the marketing authorization holder in the EU, is the German company BioNTech, not its more well-known American partner Pfizer. (See here for related documentation.)

Dyker and Matysik found that the PEI had tested and approved for release all the very bad “blue” batches, the overwhelming majority of the not-so-bad “green” batches, but almost none of the harmless “yellow” batches – as if the PEI knew in advance that these batches were unproblematic.

This is shown in the below slide from Dyker’s presentation during the Punkt.Preradovic interview. The title reads: “Which batches from the Danish study did the Paul Ehrlich Institute test and approve for release?”

In the PEI column of each of the tables, “ja” means, of course, that the batch was tested, “nein” means that it was not. Note that only the first batch in the “yellow” table was tested.


The caption under that table reads: “The PEI did not generally regard testing of the harmless ‘yellow batches’ as necessary.”

As Dyker put it, with notable restraint, “this would support the initial suspicion that they are maybe in fact something like placebos.”

Or, in short, to paraphrase the German scientists’ findings on the variability of the Pfizer-BioNTech batches, it would appear that the good was bad, the bad was very bad, and the very good was saline solution.

(The full Punkt.Preradovic interview with Gerald Dyker and Jörg Matysik is available here in German with English subtitles. The above translations are by the author.)

Published under a Creative Commons Attribution 4.0 International License
For reprints, please set the canonical link back to the original Brownstone Institute Article and Author.

Author

Robert Kogon is the pen name of a widely-published journalist covering European affairs.

View all posts
Your financial backing of Brownstone Institute goes to support writers, lawyers, scientists, economists, and other people of courage who have been professionally purged and displaced during the upheaval of our times. You can help get the truth out through their ongoing work.

'German scientists have uncovered startling evidence that a substantial portion of the batches of the Pfizer-BioNTech Covid-19 vaccine deployed in the European Union may in fact have consisted of placebos – and hence were not even subjected to quality-control testing by the German agency which was in principle responsible for approving their release.'

"The scientists, Dr. Gerald Dyker, Professor of Organic Chemistry at the Ruhr University Bochum, and Dr. Jörg Matysik, Professor of Analytical Chemistry at the University of Leipzig, are part of a group of five German-speaking scientists who have been publicly raising questions about the quality and safety of the BioNTech vaccine (as it is known in Germany) for the last year and a half. 
They recently appeared on the Punkt.Preradovic online program of the German journalist Milena Preradovic to discuss batch variability. Their starting point was the recent Danish study showing enormous variation in the adverse events associated with different batches of the Pfizer-BioNTech vaccine or BNT162b2 per its scientific codename."

https://brownstone.org/articles/scientists-uncover-evidence-eu-pfizer-biontech-batches-included-placebos/

➡️ Boost RobinMG 🚀

Fact Check: Is the Damon Imani Klaus Schwab video real? Viral 2024 WEF footage debunked
Deeksha
Modified Jan 17, 2024 16:15 GMT

follow icon Follow Us
A video circulating on the internet featuring Damon Imani allegedly hurling abuses at Klaus Schwab during the 2024 Davos Meeting, has sparked curiosity among netizens. The video claims that a 'New WEF participant does the unthinkable at 2024 Davos Meeting.' However, it is worth noting that the video is satire and the incident did not occur in reality.


Expand Tweet

For those unaware, Imani is an Iranian producer and artist based in Denmark. Specializing in creating video content covering a range of topics, including societal issues, news, and current events, Imani is known for his satirical approach.

The video of Damon Imani came at a time when the World Economic Forum (WEF) Annual Meeting held in 2024 brought together nearly 3,000 global leaders from over 125 countries to discuss the challenges and crises the world faces.

During the first plenary of the Annual Meeting, Klaus Schwab, the Founder and Executive Chairman of WEF, highlighted the need to rebuild trust in each other. Despite the geographical interconnectedness, Schwab noted that the world is currently more divided and fragmented.

The Damon Imani-Klaus Schwab video is not real

The video in question is an edited one shared by Imani. He even posted on X in which he said,

"Satire but true. This video is also available on Rumble here and Klaus Schwab can go f himself."
As social media users came across this viral video, some of them jokingly wished that it had really happened.


Expand Tweet

Imani's content gained traction between 2016 and 2020 as he garnered attention from social media users on both sides of the political spectrum as well as prominent figures like Donald Trump, Joe Rogan, Alex Jones, and Elon Musk. His work has even been featured in major media outlets such as USA Today, InfoWars, The Associated Press, and BPR Politics And Business.

This video came to light after the WEF 2024 meeting in which WEF President Borge Brende emphasized the complexity of the security landscape and the fragility of the global economy.

Brende also said,

"We have nearly 3,000 participants from more than 125 countries here at the 54th Annual Meeting of the World Economic Forum. We are seeing a very complicated security landscape and a very fragile global economy. The most urgent issues faced by companies and countries including on security, climate and cyberspace are not limited by borders. They do travel without passports."
Despite challenges, Brende seemed optimistic about cooperation among nations and companies. He looked forward to progress in addressing these pressing issues during the Davos meeting.


Fact Check: Is the Damon Imani Klaus Schwab video real? Viral 2024 WEF footage debunked
https://www.sportskeeda.com/pop-culture/news-fact-check-is-damon-imani-klaus-schwab-video-real-viral-2024-wef-footage-debunked

Scientists at the University of Southern Denmark say there’s a link between traffic noise and the risk of developing tinnitus, a subjective experience of sound (like ringing in the ears) even in a quiet room. #Health
https://www.naturalblaze.com/2024/01/live-near-a-busy-road-it-could-lead-to-a-common-hearing-problem.html

Santa Facts and NFT.

1. The world's largest gathering of Santa Clauses occurs annually in Copenhagen, Denmark, where thousands of people dressed as Santa participate in the Santa Claus World Congress.

2. The idea of Santa having a workshop at the North Pole is often attributed to the 1823 poem "A Visit from St. Nicholas," which popularized many aspects of the modern Santa Claus myth.

3. The Guinness World Record for the largest Santa Claus parade is held by Richmond, Virginia, with thousands of participants dressed as Santa.

4. In Finland, where Santa is known as Joulupukki, a tradition called "Joulupukki TV" allows children to interact with Santa via a live television broadcast.

5. The first department store Santa Claus appeared in 1890 at a store in Massachusetts, where James Edgar donned a Santa suit to attract shoppers.

6. The concept of a Naughty or Nice list has been around for centuries, but its modern interpretation as a way to monitor children's behavior and determine gifts is relatively recent.

7. In Australia, where Christmas falls during the Southern Hemisphere's summer, Santa is sometimes depicted wearing "board shorts" instead of his traditional suit.

8. The Dutch celebrate "Sinterklaas" on December 5th, where Sinterklaas arrives by boat, accompanied by his helpers, and distributes gifts to children.

9. The legend of Santa Claus has been adapted in various ways, including female versions like "Mrs. Claus" and different cultural iterations, such as "Grandfather Frost" in Russia.

10. The town of North Pole in Alaska receives thousands of letters addressed to Santa Claus each year, and volunteers known as "Santa's elves" respond to as many as possible.

Santa NFT:
https://bit.ly/3NHZ55T

#newyear #christmas #nfts #nft #buynft #nftcollectibles #nftcollection #nftart #nftartwork #nftartist #snow #winter #holidays #santa #facts

A 30-year-old Danish healthcare trainee is seeking $1.6 million in compensation through Denmark's workers' compensation program, after sustaining major injuries from a single dose of the AstraZeneca COVID-19 vaccine, Berlingske reports.

The Immune System and Vaccines are Complicated ⋆ Brownstone Institute
The Immune System and Vaccines are Complicated
SHARE | PRINT | EMAIL
Vaccines are a complicated area, which is because the immune system is immensely complicated. Targeted vaccines have ancillary effects, and it is not possible to predict what they are.

Professor Peter Aaby’s group has done ground-breaking research on the effects of vaccines in randomized trials and in field studies. His team discovered that all live, attenuated vaccines decrease total mortality whereas some non-live vaccines increase total mortality. There are also gender differences, and the sequence of vaccinations is important. It is best to end with a live vaccine.

My rule of thumb is that if a vaccine is part of the official vaccination program in some countries and not in others of similar standing, it is not important to get vaccinated. An example is the rotavirus vaccine against diarrhoea, which is not on the childhood program in Denmark even though we had a strong lobby group promoting it.

The Measles Vaccines
The measles vaccines are a good example that live, attenuated vaccines decrease total mortality much more than what is possible based on their targeted effect, in this case on preventing measles. In a randomised trial in Bissau, for example, children vaccinated against measles at age 6 months had 70 percent lower mortality than unvaccinated children, and this reduction was not due to prevention of measles infection. The WHO has estimated that there were 128,000 measles deaths globally in 2021, mostly among unvaccinated or under-vaccinated children under the age of 5 years.

If we do not vaccinate our children against measles, it will lead to many deaths and cases of severe brain damage that could have been avoided. We have a joint responsibility towards each other to ensure we get vaccinated because herd immunity is important. Measles is highly contagious, and to prevent the occurrence of measles epidemics, vaccinating about 95 percent of the population is necessary.

Annual Influenza Jabs are not Needed
People all over the world, particularly the elderly, are being nudged by the authorities to get an annual vaccination against influenza, but it is not at all obvious that this is a good idea. In fact, there are several reasons to be skeptical.

First, the preventive effect is small. Twenty-nine people would need to be vaccinated to avoid one case of influenza-like illness and 71 people to avoid one case of influenza, and the vaccination does not reduce hospital admissions or days off work.

Second, as the virus mutates quite rapidly, the effect obtained by vaccination will likely be smaller than in the randomized trials.

Third, the vaccine has negative effects on the immune system. Canadian researchers showed in four different studies that people who received a seasonal influenza vaccine in 2008 had an increased risk of getting infected with another strain in 2009.

Fourth, all vaccines cause harms, which can potentially be serious. Pandemrix, one of the influenza vaccines used during the 2009-2010 pandemic, caused narcolepsy in children and adolescents with a certain tissue type. Up to several years after vaccination of children and adolescents, people may suddenly start falling asleep while engaging in their normal activities, and there is no cure.

Fifth, we should always consider the likelihood of getting infected without vaccination. Influenza pandemics are uncommon and rarely involve large portions of the population. In any given year, the likelihood of acquiring influenza if unvaccinated is therefore very small. I never had an influenza vaccination, and my wife, a professor in clinical microbiology, never had one, and together, we have perhaps had influenza twice for 135 years. But we don’t know. When people say they have influenza, it usually just means an influenza-like illness of which there are many, which vaccination does not protect against.

Some fundamentalists, particularly in the United States and Australia, have mandated influenza vaccination of healthcare workers to protect patients. This violation of informed consent is deeply troubling and unethical. Moreover, a large review about vaccination of healthcare workers caring for elderly people did not find an effect on laboratory-proven influenza, lower respiratory tract infection, hospitalisation, death due to lower respiratory tract illness, or all-cause mortality.

A researcher mentioned that, “to focus exclusively on the risk posed by unvaccinated workers – treating them as outcasts or, worse, terminating their employment – while overlooking the risk posed by vaccinated workers, potentially jeopardizes patients.” Indeed. Vaccination may provide staff with a false sense of security that might reduce their level of handwashing and potentially increase, rather than decrease, the risk of infecting patients.

HPV Vaccines: Not a Simple Issue
When the HPV vaccines were suspected of causing serious neurological harms – postural orthostatic tachycardia syndrome (POTS), complex regional pain syndrome (CRPS), and chronic fatigue syndrome – the European Drug Agency cleared the vaccines. However, they did not investigate the issues themselves but let the manufacturers do it for them.

My research group examined the clinical study reports submitted to the European Medicines Agency and found a significant increase in serious neurological harms. This was surprising because almost everyone in the control groups had been treated with a hepatitis vaccine or a strongly immunogenic adjuvant, which might also cause harms, making it difficult to detect the harms of the HPV vaccines.

The Cochrane review of the HPV vaccines was incomplete and ignored important evidence of bias. The authors overlooked several adverse events and failed to mention that some of the included trials did not report serious adverse events for the whole trial period. For example, three Gardasil trials with a total of 21,441 girls or women with up to four years follow-up only reported serious adverse events occurring within 14 days post-vaccination even though it takes years in many patients before serious neurological harms get diagnosed.

The Cochrane authors found more deaths in the HPV vaccine groups than in the comparator groups, and the death rate was significantly increased in women above age 25, risk ratio 2.36 (95 percent confidence interval 1.10 to 5.03). They considered this a chance occurrence since there was no pattern in the causes of death or in the time between vaccine administration and death.

However, deaths are often miscoded. For example, traumatic head injury and drowning in a bathtub have been described, and this could have been caused by a syncope or near syncope, which is a recognized vaccine harm that can occur at any time. The serious neurological harms seem to be caused by an autoimmune reaction.

The drug companies, EMA and Cochrane called the trials placebo-controlled, which they weren’t. I find it shocking that vaccines are not tested against placebo or no treatment because this makes it impossible to ever know with certainty what the rare but serious harms are. There is no good reason why vaccines – which are preventative drugs – are not tested in the same rigorous way as other drugs.

EMA declared that the adjuvants used in the vaccines to boost the immune response are safe, but the five references provided in support of this view were either non-accessible or irrelevant. Furthermore, nothing is safe if it is active. GlaxoSmithKline has stated that its aluminum-based comparator might cause harms, and the clinical study reports show that this is also the case for Merck’s adjuvant.

The decision-making is not straightforward. The official propaganda has made women believe that cervical cancer is a major threat to their lives, but this cancer only contributes 0.5 percent of all deaths. Thus, very few women can benefit from the HPV vaccines, and since they do not protect against all HPV types, regular screening is still recommended even for women who are vaccinated. As the precursors to cancer are very slow-growing, women can avoid getting cervical cancer if they go to screening. This is more effective than getting vaccinated, but it comes with a price, e.g. conization for cancer precursors increases the risk of preterm birth.

COVID-19 Vaccines: A Mess
The story of the COVID-19 vaccines is officially touted as one of success but what stands out is a story of massive deceit and lack of scientific evidence behind many of the recommendations.

The randomized trials that led to emergency approval of the vaccines showed that only one of 50 severe cases of COVID-19 occurred in the vaccine groups. This makes it likely that the vaccines have saved lives, and meta-analyses of the trials showed that the adenovirus vector vaccines, but not the mRNA vaccines, decreased total mortality significantly.

The hype has been extreme, however. Among those that have claimed 100 percent efficacy of the vaccines are the FDA, US presidential advisor Anthony Fauci, the Australian government, Science Magazine, Reuters, CNN, US National Public Radio, The Hill, Sky News, Pfizer, Moderna, AstraZeneca, and Johnson & Johnson. The efficacy is closer to 50 percent and many people, including me, have become infected despite having received two or more doses of the vaccine.

Officials, including US President Joe Biden, once claimed that the vaccines were 100 percent protective against transmission to other people, but now it is widely acknowledged that there is no evidence that the vaccines can prevent transmission.

The information on the website of the US Centers for Disease Control and Prevention (CDC) is particularly misleading. The CDC uses industry jargon when claiming that the vaccines are “safe and effective.” It states that “Adults and children may have some side effects from a COVID-19 vaccine, including pain, redness or swelling at the injection site, tiredness, headache, muscle pain, chills, fever, and nausea. These side effects typically resolve after a few days.  Serious side effects are rare but may occur.”

The link to serious side effects does not lead to any mention of what those are. But we know that the vaccines kill some people, e.g. because they can cause myocarditis, most commonly in young males, and thromboses.

The CDC recommends “everyone ages 6 months and older get an updated COVID-19 vaccine to protect against serious illness.” However, children tolerate the infection very well and it is likely harmful to vaccine children against COVID-19. Moreover, boosters may be harmful at any age but this is not popular information either. Facebook censored research and an interview with top vaccine researcher Professor Christine Stabell Benn even though the European Medicines Agency was also worried that COVID-19 vaccine boosters might be “overloading people’s immune systems and leading to fatigue.”

Facebook also censored research that showed that the mRNA COVID-19 vaccines could weaken the immune response and make cells of the immune system “lazy” when it comes to fighting off viral and bacterial infections. Facebook called this research “false information.”

The Cochrane Collaboration, which has the logo “Trusted information,” did not provide trusted information. The Cochrane authors used industry jargon in the title of their review, “Efficacy and safety of COVID‐19 vaccines,” even though I convinced Cochrane many years ago that we should talk about benefits and harms of the interventions we study, in agreement with the CONSORT guidelines for good reporting of harms in trials, which I coauthored in 2004.

The Cochrane authors concluded that there is little or no difference in serious adverse events compared to placebo whereas Peter Doshi and colleagues who reanalysed the pivotal mRNA trials found that one additional serious adverse event occurred for every 800 people vaccinated with an mRNA vaccine. Their article, published four months before the Cochrane review, was not cited in it.

When I studied the pivotal randomised trials, which were published in the New England Journal of Medicine and in the Lancet, I found that essential data on serious and severe harms were missing (see also my freely available book, The Chinese virus: killed millions and scientific freedom).

Doshi et al.’s criticism of the Cochrane review, which is published within the review itself, is so substantial that it is fair to call the Cochrane review a politically expedient garbage in, garbage out exercise.

There can be no doubt that the COVID-19 vaccines are much overused and partly to the wrong people. Now that most of us have had the infection, recommending booster after booster seems to be a particularly bad idea.

Childhood Vaccines
The childhood vaccination programs differ a lot from country to country. In the US, 17 vaccines are recommended, in Denmark only 10.

Since vaccinations can weaken the immune system and since some non-live vaccines increase total mortality, it is reasonable to ask if the many vaccinations in the US could result in net harm.

It is very important to study this possibility, but I am only aware of two researchers who have done it. They did several studies and found that those nations that require more vaccines for their infants have higher infant mortality, neonatal mortality, and under age five mortality. I find this an alarm signal that should lead to other studies as a matter of urgency.

Censorship
Censorship is detrimental for scientific debate and scientific advances, and it is harmful for the patients. But for vaccines, it is all over the place.

Peter Aaby, one of the world’s top vaccine researchers, lectured about vaccines at the opening symposium for my Institute for Scientific Freedom in March 2019. In early November 2021, YouTube removed the video of his lecture. Everything he said was correct and important for people who want to understand what vaccines do. We appealed this outrageous act of censorship, but to no avail, and I therefore uploaded his lecture on my own website.

In February 2022, a US lawyer wrote a 3-page letter to Susan Wojcicki, Chief Operating Officer, Legal Support, YouTube, asking her to restore Professor Aaby’s video about the beneficial and harmful effects of vaccines so that a healthy conversation surrounding medical science could continue. The lawyer received an automated message saying that the video had violated YouTube’s Community Guidelines, adding that “If you think a Community Guidelines strike was applied to your account in error, you can appeal it.” The lawyer appealed and received no reply.

In July 2022, Christine Stabel Benn uploaded a videocast with Peter Aaby on YouTube about his research in Africa, which mainly addressed his discovery of the beneficial non-specific effects of measles vaccines. But Aaby also mentioned his interactions with the WHO related to the introduction of a high-titre measles vaccine, which he and his colleagues’ studies had shown increased mortality in girls.

Initially, the WHO did not react, but when American colleagues confirmed Aaby’s findings in Haiti, the high-titre vaccine was withdrawn. It has been estimated that this vaccine would have cost around 0.5 million lives per year in Africa alone. It is an important lesson that a highly beneficial vaccine that has saved millions of lives can kill millions if used in too high doses. But YouTube quickly removed the videocast due to “inappropriate content.” Censorship kills. It is as simple as that.

In September 2022, I was interviewed by enGrama in Spain for an hour about organised crime in psychiatry and the drug industry. I spoke about COVID-19 for 5 minutes, which made YouTube instantly eliminate the whole interview. This was utterly ridiculous. What I said was true, but YouTube even refused to allow the interviewers to download their own video. Later, they succeeded to reproduce it via the YouTube Studio and it is now up again, but without the forbidden 5 minutes. I have described verbatim what they were about.

I was convinced – and still am – that the pandemic was caused by a laboratory leak in Wuhan and that the virus was manufactured there; that repeated vaccinations could weaken the immune response; and that the vaccines can cause serious harm, even death. All of which is considered taboo by social media.

In September 2023, I launched an evidence-based podcast channel, Broken Medical Science, in collaboration with documentary filmmaker Janus Bang. To avoid censorship, we have our own server but also publish the episodes on social media. I interviewed Professor Martin Kulldorff, one of the authors of the Great Barrington Declaration, about “The harmful effects of lockdowns, facemask mandates, censorship, and scientific dishonesty,” and Christine Stabell Benn about “Vaccines, a complicated area. Some decrease total mortality, some increase it, and COVID-19 vaccines are overused.”

Within 7 minutes after we uploaded these episodes on YouTube, they got this label: “COVID-19 vaccine. Learn about vaccine progress from the WHO.” But some of the WHO’s information was questionable, which we addressed in our newsletter:

What are the benefits of getting vaccinated against COVID-19?

One should always ask what the benefits and harms are, of any intervention. The vaccines have killed some people because of myocarditis and thromboses.

Getting vaccinated could save your life. COVID-19 vaccines have saved millions of lives.

What is the evidence for this? The vaccines are not particularly effective because the virus mutates.

Consider continuing to practice protective and preventive behaviours such as keeping a distance, wearing a mask in crowded and poorly ventilated spaces.

The randomized trials have not found any effect of face masks.

Even if you have had COVID-19, the WHO still recommends that you get vaccinated after infection because vaccination enhances your protection against severe outcomes of future COVID-19 infection, and you may be protected for longer. Furthermore, hybrid immunity resulting from vaccine and infection may provide superior protection against existing variants of concern.

This has not been documented, and many researchers doubt that it is correct.

To ensure optimal protection, it is important to receive COVID-19 vaccine doses and boosters recommended to you by your health authority.

It has not been documented that boosters are beneficial, and the European Medicines Agency has warned that boosters may be harmful, as they may weaken the immune system.

In both cases, within a couple of hours, YouTube removed the link to the WHO, with no explanation. We speculate that perhaps YouTube is worried about their reputation. I had interviewed two of the most knowledgeable people in the world about vaccines who, to some extent, contradicted the WHO’s recommendations, based on solid science.

It is time to change the paradigm about vaccines, and to study them more thoroughly – and their combinations – before they are possibly allowed onto the market.

A Final Word about Censorship
My deputy director, PhD Maryanne Demasi, and I have been unable to publish our systematic review of serious harms of the COVID-19 vaccines in a medical journal. This is not because I don’t know how to do research and publish it in good journals. I have published over 100 papers in “the big five” (BMJ, Lancet, JAMA, Annals of Internal Medicine and New England Journal of Medicine) and my scientific works have been cited over 190,000 times.


Published under a Creative Commons Attribution 4.0 International License
For reprints, please set the canonical link back to the original Brownstone Institute Article and Author.

Dr. Peter Gøtzsche co-founded the Cochrane Collaboration, once considered the world’s preeminent independent medical research organization. In 2010 Gøtzsche was named Professor of Clinical Research Design and Analysis at the University of Copenhagen. Gøtzsche has published more than 97 papers in the “big five” medical journals (JAMA, Lancet, New England Journal of Medicine, British Medical Journal, and Annals of Internal Medicine). Gøtzsche has also authored books on medical issues including Deadly Medicines and Organized Crime. Following many years of being an outspoken critic of the corruption of science by pharmaceutical companies, Gøtzsche’s membership on the governing board of Cochrane was terminated by its Board of Trustees in September, 2018. Four board resigned in protest.


https://brownstone.org/articles/the-immune-system-and-vaccines-are-complicated/

Happy Easter in Denmark ???? Lunch time ☀️

On 6 May 1950, two brothers came upon a body in Jutland, Denmark. The body was so well preserved that they thought it was a recent death.

Upon closer examination, it was realized that the body was actually a man from the 4th century BC.

Known as Tollund Man, he lived in what is now Silkeborg, Denmark and was around 40 years of age at his time of death, at a height of over 5 feet tall.

It is thought that the Tollund man was a sacrifice, then was placed in a peat bog which preserved him. #somee #history #archeology #cent #waiv

The doors are closed and we are ready to go! The train from Denmark was canceled so we got a new train here in Malmö. It’s also longer (240m) then what we are supposed to have.

#awesme

Today I have taken the train from Sweden ???????? over to Denmark ???????? via the bridge and the artificial island that was the foundation to the hole in the ocean. And then on just pops up at the AirPort! So easy and convenient ;) I passed Stockholm Archipelago later on also and they even have a skislope on one of their islands in the city centre #someetraveling

Even though it's Monday, the Coven Garden is crowded. Because we were in the area for work, we took the chance to go for a short walk at the Market and enjoy a hot cup of tea. ????

Happy #Monday everyone! ????

#SomeeEvolution #Somee #Hive #OriginalContentOnly #WorkingDay #CovenGardenMarket